KCT0001180已完成未知
A Randomised, Double-Blind, Placebo-Controlled, Single-Centre, Phase IIa Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- Celltrion
- 入组人数
- 81
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 45(Year)（—）
- 性别
- All
入选标准
- •Healthy Male & Female volunteers
排除标准
- •Current clinically significant disease
- •Pregnant or nursing mother
- •Abnormal pulmonary function, nose or nasopharynx
研究者
相似试验
已完成
不适用
A Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food on the Pharmacokinetics of DRL-17822 in Healthy Adult Male Volunteerscoronary heart disease10011082AtherosclerosisNL-OMON33454Dr. Reddy's Laboratories Ltd.72
招募中
不适用
A Randomised, Double-Blind, Placebo-Controlled, Single- and Multiple-, Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of VRG50635 and Food Effect in Healthy Volunteers (Phase 1a)Amyotrophic lateral sclerosis10041543NL-OMON56052Verge Genomics84
已完成
1 期
Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male SubjectsJapanese Healthy Male ParticipantsJPRN-jRCT2080223605Takeda Pharmaceutical Company Limited24
已完成
1 期
Safety, Tolerability and Pharmacokinetics of ALD1910MigraineACTRN12619001380189Alder BioPharmaceuticals, Inc.96
已完成
1 期
A Study to Assess the effect of Subcutaneous APL-2 in Healthy Adult SubjectsACTRN12614000725662Clinical Network Services (CNS) Pty Ltd31